Export 550 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
W. Wu, Lee, I., Spratt, H., Fang, X., and Bao, X., tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms., J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
T. Nikolai, Stepankova, H., Kopecek, M., Sulc, Z., Vyhnálek, M., and Bezdicek, O., The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective., J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
A. Loughman, Adler, C. J., and Macpherson, H., Unlocking Modifiable Risk Factors for Alzheimer's Disease: Does the Oral Microbiome Hold Some of the Keys?, J Alzheimers Dis, vol. 92, no. 4, pp. 1111-1129, 2023.
M. A. Schilling, Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1., J Alzheimers Dis, vol. 51, no. 4, pp. 961-77, 2016.
B. Seok Ye, Jang, E. Young, Kim, S. Yoon, Kim, E. - J., Park, S. Ah, Lee, Y., Hong, C. Hyung, Choi, S. Hye, Yoon, B., Yoon, S. Jin, Na, H. Ri, Lee, J. - H., Jeong, J. H., Kim, H. Jin, Na, D. L., and Seo, S. Won, Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
S. Chand Basha, Ramaiah, M. Janaki, and Kosagisharaf, J. Rao, Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S319-S333, 2023.
S. Merighi, Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. Emanuele, Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. Andrea, and Gessi, S., Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
C. Marra, Gainotti, G., Fadda, L., Perri, R., Lacidogna, G., Scaricamazza, E., Piccininni, C., and Quaranta, D., Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS)., J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
H. Shinagawa, Ohuchi, K., Goto, Y., Hashimoto, K., Kijima, H., Maekawa, S., Kurita, H., and Inden, M., Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
X. Feng, Zhou, A., Liu, Z., Li, F., Wei, C., Zhang, G., and Jia, J., Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese., J Alzheimers Dis, vol. 61, no. 4, pp. 1611-1618, 2018.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
A. L. Jefferson, Gifford, K. A., Mae Y Acosta, L., Bell, S. P., Donahue, M. J., L Davis, T., Gottlieb, J. A., Gupta, D. K., Hohman, T. J., Lane, E. M., Libon, D. J., Mendes, L. A., Niswender, K., Pechman, K. R., Rane, S., Ruberg, F. L., Su, Y. Ru, Zetterberg, H., and Liu, D., The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview., J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
J. Li, Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., and Zhou, H. D., Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease., Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., VEGFR1 and VEGFR2 in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
S. E. Leh, Kälin, A. M., Schroeder, C., Park, M. Tae M., M Chakravarty, M., Freund, P., Gietl, A. F., Riese, F., Kollias, S., Hock, C., and Michels, L., Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment., J Alzheimers Dis, vol. 49, no. 1, pp. 237-49, 2016.
D. Andriuta, Moullart, V., Schraen, S., Devendeville, A., Meyer, M. - E., and Godefroy, O., What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
C. Reed, Happich, M., Argimon, J. Maria, Haro, J. Maria, Wimo, A., Bruno, G., Dodel, R., Jones, R. W., Vellas, B., and Belger, M., What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study., J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
T. Rivasseau Jonveaux and Fescharek, R., When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 885-898, 2018.
R. Sánchez-Valle, Monté, G. C., Sala-Llonch, R., Bosch, B., Fortea, J., Lladó, A., Antonell, A., Balasa, M., Bargalló, N., and Molinuevo, J. Luis, White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.
J. - P. Coutu, Goldblatt, A., H Rosas, D., and Salat, D. H., White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
K. Metsla, Kirss, S., Laks, K., Sildnik, G., Palgi, M., Palumaa, T., Tõugu, V., and Palumaa, P., α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.